RING
Ring Therapeutics, Inc.
Mark For: RING® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88744777 |
| Registration Number | 1544287 |
| Mark Literal Elements | RING |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2023-03-09 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Christina M. Licursi, Esq. |
| Attorney Docket Number | V03222000700 |
Timeline
| 2020-01-02 | Application Filed |
| 2020-01-08 | Location: NEW APPLICATION PROCESSING |
| 2020-01-08 | Status: Live/Pending |
| 2020-01-10 | Transaction Date |
| 2020-07-07 | Published |
| 2023-03-09 | Location: INTENT TO USE SECTION |
| 2023-10-02 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
Trademark Parties (Applicants & Owners)
| Party: |  Ring Therapeutics, Inc. |
| Address | 55 Cambridge Parkway, Suite 800E Cambridge, MASSACHUSETTS UNITED STATES 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | 2020-01-02 | |
| TEAS RF New Application | 2020-01-02 | |
| Offc Action Outgoing | 2020-03-24 | |
| XSearch Search Summary | 2020-03-24 | |
| Response to Office Action | 2020-05-26 | |
| Amendment and Mail Process Complete | 2020-05-28 | |
| TRAM Snapshot of App at Pub for Oppostn | 2020-05-30 | |
| Notice of Publication | 2020-06-17 | |
| Notification Of Notice of Publication | 2020-06-17 | |
| OG Publication Confirmation | 2020-07-07 | |
| Notice of Allowance | 2020-09-01 | |
| Extension of Time to File SOU | 2021-03-01 | |
| ITU Extension Approval | 2021-03-03 | |
| ITU Unit Action | 2021-03-03 | |
| Extension of Time to File SOU | 2021-08-25 | |
| ITU Extension Approval | 2021-08-27 | |
| ITU Unit Action | 2021-08-27 | |
| Extension of Time to File SOU | 2022-02-28 | |
| ITU Extension Approval | 2022-03-03 | |
| ITU Unit Action | 2022-03-03 | |
| Extension of Time to File SOU | 2022-08-30 | |
| ITU Extension Approval | 2022-09-01 | |
| ITU Unit Action | 2022-09-01 | |
| Extension of Time to File SOU | 2023-02-24 | |
| ITU Extension Approval | 2023-03-10 | |
| ITU Unit Action | 2023-03-10 | |
| Notice of Abandonment | 2023-10-02 | |
| ITU Unit Action | 2023-10-03 |
Attorney of Record
Good, Services, and Codes
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Encapsulated nucleic acids for use as biological therapeutics in for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease; pharmaceutical preparations for use in gene therapy |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2023-10-02 | |
| ABANDONMENT - NO USE STATEMENT FILED | 2023-10-02 | 99999 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-03-10 | |
| SOU EXTENSION 5 GRANTED | 2023-03-09 | 66230 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-03-09 | 66230 |
| SOU TEAS EXTENSION RECEIVED | 2023-02-24 | |
| SOU EXTENSION 5 FILED | 2023-02-24 | 66230 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-09-01 | |
| SOU TEAS EXTENSION RECEIVED | 2022-08-30 | |
| SOU EXTENSION 4 GRANTED | 2022-08-30 | 98765 |
| SOU EXTENSION 4 FILED | 2022-08-30 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-03-03 | |
| SOU TEAS EXTENSION RECEIVED | 2022-02-28 | |
| SOU EXTENSION 3 GRANTED | 2022-02-28 | 98765 |
| SOU EXTENSION 3 FILED | 2022-02-28 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-08-27 | |
| SOU TEAS EXTENSION RECEIVED | 2021-08-25 | |
| SOU EXTENSION 2 GRANTED | 2021-08-25 | 98765 |
| SOU EXTENSION 2 FILED | 2021-08-25 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-03 | |
| SOU TEAS EXTENSION RECEIVED | 2021-03-01 | |
| SOU EXTENSION 1 GRANTED | 2021-03-01 | 98765 |
| SOU EXTENSION 1 FILED | 2021-03-01 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-09-01 | |
| PUBLISHED FOR OPPOSITION | 2020-07-07 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-07-07 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-06-17 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-29 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-27 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-26 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-26 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-03-24 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-03-24 | 91232 |
| NON-FINAL ACTION E-MAILED | 2020-03-24 | 6325 |
| ASSIGNED TO EXAMINER | 2020-03-24 | 91232 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2020-01-09 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 